Clinical trial · Observational
Adipokines in Polycystic Ovary Syndrome
Assessment of Adipokine Concentrations and Their Association With the Metabolic Profile of Women With PCOS
NCT06793072CI-TRIAL-00105797recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of the study is to compare the concentrations of leptin, resistin, and omentin-1 in women across three research groups: those with polycystic ovary syndrome without insulin resistance, those with polycystic ovary syndrome with insulin resistance, and women without polycystic ovary syndrome.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| PCOS | — | UNRESOLVED | — |
| Reproductive Age | — | UNRESOLVED | — |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Leptin concentration in blood serum | Diagnostic Test | — | UNRESOLVED |
| Omentin-1 concentration in blood serum | Diagnostic Test | — | UNRESOLVED |
| Resistin concentration in blood serum | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- label
- PCOS+IR
- description
- Polycystic ovary syndrome + insulin resistance
- interventionNames
- Diagnostic Test: Leptin concentration in blood serum
- Diagnostic Test: Resistin concentration in blood serum
- Diagnostic Test: Omentin-1 concentration in blood serum
- label
- PCOS + no IR
- description
- Polycystic ovary syndrome + no insulin resistance
- interventionNames
- Diagnostic Test: Leptin concentration in blood serum
- Diagnostic Test: Resistin concentration in blood serum
- Diagnostic Test: Omentin-1 concentration in blood serum
- label
- No PCOS
- description
- Women without PCOS (control)
- interventionNames
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 45 Years
Show eligibility criteria text
Inclusion Criteria: * Age 18-45 Exclusion Criteria: * previous removal of at least one ovary * treated diabetes of any type * diagnosed and treated metabolic diseases * diagnosed and treated autoimmune diseases * diagnosed and treated autoinflammatory diseases(Edited)Restore original
References
Publications (0)
Data not yet available
No reference posted for this study.